Skip to main content
. 2025 Nov 27;100(1):309–316. doi: 10.1038/s41390-025-04633-6

Table 1.

Baseline and perinatal characteristics.

HD (N = 279) LD (N = 304)
Sex
 Female N (%) 127 (45.8) 144 (47.4)
 Male N (%) 150 (54.2) 160 (52.6)
 Gestational age (weeks) Mean (SD) 29.19 (1.90) 28.92 (2.02)
 Birthweight (g) Mean (SD) 1180.44 (232.76) 1154.32 (243.51)
 Intrauterine growth restriction N (%) 60 (21.6) 70 (22.3)
 Preeclampsia N (%) 49 (17,6) 60 (19.7)
 Corticoids use N (%) 251 (91.3) 270 (88.8)
 Antibiotics use N (%) 171 (62.2) 180 (59.4)
 Membranes ruptured > 24 h before birth N (%) 76 (27.3) 79 (26.0)
 Chorioamnionitis N (%) 31 (11.2) 38 (12.5)
Type of delivery
 Vaginal N (%) 72 (25.9) 96 (31.7)
 C-section N (%) 206 (74.1) 207 (68.3)
APGAR 5
 0–3 N (%) 3 (1.1) 3 (1.0)
 4–6 N (%) 13 (4.8) 34 (11.4)
 7–10 N (%) 254 (94.0) 260 (87.5)
 Reanimation N (%) 251 (90.3) 275 (90.5)
Type of reanimation
 Reanimation type I N (%) 47 (18.8) 52 (18.9)
 Reanimation type II N (%) 34 (13.6) 37 (13.5)
 Reanimation type III N (%) 120 (48.0) 135 (49.1)
 Reanimation type IV N (%) 42 (16.8) 47 (17.1)
 Reanimation type V N (%) 7 (2.8) 4 (1.5)
 Time to EN initiation (hours) Mean (SD) 24.96 (14.59) 25.09 (15.22)
 Initial volume of EN (ml/kg/day) Mean (SD) 13.70 (9.82) 13.97 (9.05)
Type of milk received
 Donated breast milk N (%) 127 (45.7) 145 (47.7)
 Infant formula N (%) 57 (20.5) 54 (17.8)
 Maternal milk N (%) 65 (23.4) 67 (22.0)
 Mixed N (%) 29 (10.4) 38 (12.5)

Values are means (SD) for continuous variables and n (%) for categorical variables. P indicates differences between treatment groups.

HD high dose, LD low dose, N number of patients, SD standard deviation, EN enteral nutrition. The “Maternal milk” category may include supplementation with donor milk.